Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Telsey Advisory Cuts Price Target On Peloton Interactive By 26%

By Shivani Kumaresan
July 13, 1:43 PM
Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating for Peloton Interactive Inc (NASDAQ: PTON), citing the lack of visibility into demand levels, profitability, and cash flow.

PTON

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Reiteration
  • Small Cap
  • Trading Ideas

Mizuho On Atara Biotherapeutics – Distinguish Between Small Numbers And Science Failure

By Vandana Singh
July 13, 1:39 PM
Atara Biotherapeutics Inc (NASDAQ:ATRA) issued its anticipated interim analysis communication for its ATA188 Phase 2 progressive multiple sclerosis trial. Shares slumped…

ATRA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Strong Fundamentals But Valuation High: Why Analysts Are On The Sidelines Of Pepsi Stock

By Chris Katje
July 13, 12:10 PM
Beverage and snack food company PepsiCo, Inc. (NYSE: PEP) reported second-quarter financial results before market open Tuesday.

PEP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target

By Benzinga Newsdesk
July 13, 8:19 AM
Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $1 price target.

TXMD

Read More
1 minute read
  • Analyst Ratings
  • General
  • News
  • Penny Stocks
  • Price Target
  • Reiteration

EF Hutton Remains Bullish On This Energy Company – Read Why

By Shivani Kumaresan
July 12, 1:57 PM
EF Hutton analyst Ben Piggott reiterated a Buy rating on U.S. Energy Corp (NASDAQ:USEG) and increased the price target to $7 from $6.25…

USEG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap

Telsey Advisory Thinks This Recently Listed Consumer Products Company Is Taking Right Steps

By Shivani Kumaresan
July 11, 2:39 PM
Telsey Advisory Group analyst Dana Telsey has reiterated Outperform rating on Grove Collaborative Holdings Inc (NYSE:GROV) shares, with a price target of $10.00. Last week,…

GROV

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Markets
  • News
  • Price Target
  • Reiteration
  • Top Stories

4 Catalysts Moving Nio Stock On Monday

By Wayne Duggan
July 11, 11:01 AM
Shares of Nio Inc - ADR (NYSE: NIO) were trading lower Monday as China deals with surging COVID-19 cases and Nio announced it is forming a committee to investigate recent short seller allegations.

BABA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Trading Ideas

Needham Cuts Price Target On This NASH-Focused Stock As Its Awaits Visibility On Regulatory Path

By Vandana Singh
July 8, 12:53 PM
Yesterday, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced data from the new interim analysis of the Phase 3 REGENERATE trial evaluating obeticholic acid in…

ICPT

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Telsey Advisory Says Costco Is ‘Executing Well’; Sees Notable Upside

By Shivani Kumaresan
July 8, 12:29 PM
Telsey Advisory Group analyst Joseph Feldman reiterated its Outperform rating on Costco Wholesale Corp (NASDAQ:COST) shares with a price target of $590 (17%…

COST

Read More
2 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Needham Reasons How TSMC’s N3E May Become Industry’s Most Favored FinFET Node

By Anusuya Lahiri
July 8, 11:56 AM
Needham analysts shared the key takeaways from Taiwan Semiconductor Manufacturing Company Ltd's (NYSE: TSM) 2022 Technology Symposium.

INTC

Posts pagination

Previous 1 … 395 396 397 … 399 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service